Table 1.
Melanoma | Breast cancer | |||
---|---|---|---|---|
Genotype | Foxp3Ctr | Foxp3ΔItgβ8 | Foxp3Ctr | Foxp3ΔItgβ8 |
Number of mice | 16 | 16 | 16 | 16 |
Number of mice with non-measurable tumor | 0 | 4 | 1 | 8 |
Percentage of mice with non-measurable tumor | (0%) | (25%) | (6.25%) | (50%) |
Foxp3ΔItgβ8 mice and their littermate controls (Foxp3Ctrl) were injected either i.d. with melanoma (B16 cells) or in the mammary gland with breast cancer (E0771 cells). Table showing the percentage of Foxp3ΔItgβ8 mice and Foxp3WT mice with a completed control of tumor growth (tumor < 100 mm3 all along the experiments) for both melanoma and breast cancer 18 days after implantation.